Stephens Inc. AR raised its stake in shares of UnitedHealth Group Inc (NYSE:UNH) by 12.0% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 48,709 shares of the healthcare conglomerate’s stock after buying an additional 5,229 shares during the quarter. Stephens Inc. AR’s holdings in UnitedHealth Group were worth $12,134,000 at the end of the most recent reporting period.
Several other hedge funds have also bought and sold shares of the company. Oregon Public Employees Retirement Fund raised its position in UnitedHealth Group by 50,446.5% in the fourth quarter. Oregon Public Employees Retirement Fund now owns 53,349,795 shares of the healthcare conglomerate’s stock valued at $214,000 after purchasing an additional 53,244,249 shares during the period. Capital International Investors increased its position in shares of UnitedHealth Group by 223.0% during the third quarter. Capital International Investors now owns 16,319,843 shares of the healthcare conglomerate’s stock worth $4,341,731,000 after acquiring an additional 11,267,910 shares during the last quarter. BlackRock Inc. increased its position in shares of UnitedHealth Group by 3.1% during the fourth quarter. BlackRock Inc. now owns 69,831,381 shares of the healthcare conglomerate’s stock worth $17,396,391,000 after acquiring an additional 2,123,417 shares during the last quarter. Rehmann Capital Advisory Group increased its position in shares of UnitedHealth Group by 26,088.2% during the third quarter. Rehmann Capital Advisory Group now owns 1,723,185 shares of the healthcare conglomerate’s stock worth $6,477,000 after acquiring an additional 1,716,605 shares during the last quarter. Finally, FMR LLC increased its position in shares of UnitedHealth Group by 2.6% during the third quarter. FMR LLC now owns 63,247,814 shares of the healthcare conglomerate’s stock worth $16,826,448,000 after acquiring an additional 1,625,459 shares during the last quarter. Institutional investors and hedge funds own 86.68% of the company’s stock.
A number of brokerages have recently issued reports on UNH. Stephens assumed coverage on UnitedHealth Group in a research report on Monday, January 14th. They set an “overweight” rating and a $287.00 target price on the stock. ValuEngine downgraded UnitedHealth Group from a “hold” rating to a “sell” rating in a research note on Thursday. Zacks Investment Research upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $279.00 price target for the company in a research note on Saturday, January 5th. Barclays decreased their target price on UnitedHealth Group from $290.00 to $270.00 and set an “overweight” rating for the company in a research note on Wednesday. Finally, SunTrust Banks decreased their target price on UnitedHealth Group to $300.00 and set a “buy” rating for the company in a research note on Wednesday. They noted that the move was a valuation call. One investment analyst has rated the stock with a sell rating, one has issued a hold rating, eighteen have assigned a buy rating and one has given a strong buy rating to the company. The company currently has a consensus rating of “Buy” and an average target price of $291.56.
Shares of NYSE UNH traded up $4.91 during trading on Friday, hitting $221.75. The company had a trading volume of 13,927,214 shares, compared to its average volume of 7,290,230. The stock has a market capitalization of $212.78 billion, a P/E ratio of 17.22, a P/E/G ratio of 1.19 and a beta of 0.79. UnitedHealth Group Inc has a 52 week low of $208.07 and a 52 week high of $287.94. The company has a debt-to-equity ratio of 0.63, a quick ratio of 0.73 and a current ratio of 0.73.
UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $3.73 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $3.60 by $0.13. UnitedHealth Group had a return on equity of 25.07% and a net margin of 5.45%. The company had revenue of $60.30 billion for the quarter, compared to analysts’ expectations of $59.72 billion. During the same quarter in the prior year, the company earned $3.04 earnings per share. The firm’s revenue was up 9.2% on a year-over-year basis. On average, research analysts forecast that UnitedHealth Group Inc will post 14.7 earnings per share for the current year.
COPYRIGHT VIOLATION NOTICE: “Stephens Inc. AR Acquires 5,229 Shares of UnitedHealth Group Inc (UNH)” was first reported by Baseball Daily News and is the property of of Baseball Daily News. If you are reading this piece on another website, it was stolen and reposted in violation of U.S. & international copyright and trademark law. The correct version of this piece can be read at https://www.baseballdailydigest.com/news/2019/04/21/unitedhealth-group-inc-unh-shares-bought-by-stephens-inc-ar.html.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Read More: How is an ETF different from a mutual fund?
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.